Yansen Bai

Prof. Dr. Yansen Bai

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in Redox Biology
Verified
Journal Article
Open access
YZYuyu Zheng
Yuyu Zheng
WLWanlu Liu
Wanlu Liu
XZXinyu Zhu
Xinyu Zhu
MXMengya Xu
Mengya Xu
BLBaihao Lin
Baihao Lin
YBYansen Bai
Yansen Bai
Previous studies have shown that inflammatory and antioxidant dietary patterns can modify the risk of COPD, yet few studies have examined the association of these diets with its early signs (PRISm), and the potential role of metabolic disorders remains to be elucidated. Data from 9529 individuals who participated in the 2007-2012 National Health and Nutrition Examination Survey (NHANES) were analyzed. The Dietary Inflammation Index (DII) and the Dietary Antioxidant Composite Index (CDAI) were assessed using 24-h dietary recall, multiple metabolic indicators were calculated according to biochemical markers, and lung function parameters defined PRISm cases. Individual and joint effects of DII and CDAI were evaluated by generalized linear models and binary logistic regression models, and mediation effects of metabolic indicators were further explored by causal mediation analysis. Increased DII was associated with decreased lung function (FEV1: β = -18.82, FVC: β = -29.2; OR = 1.04) and increased metabolic indicators (β = 0.316, 0.036, 0.916, 0.033, and 0.145 on MAP, UA, TC, TyG, and MS, respectively). Contrary to this, CDAI were positively and negatively associated with lung function (FEV1: β = 3.42; FVC: β = 4.91; PRISm: OR = 0.99) and metabolic indicators (β < 0), respectively. Joint effects of DII and CDAI indicated the minimal hazard effects of DII on TyG (β = -0.11), FEV1 (β = 72.62), FVC (β = 122.27), and PRISm (OR = 0.79) in subjects with high CDAI when compared with those with low CDAI (low DII + high CDAI vs. high DII + low CDAI). Furthermore, TyG mediated 13.74 %, 8.29 %, and 21.70 % of DII- and 37.30 %, 20.90 %, and 12.32 % of CDAI-FEV1, -FVC, and -PRISm associations, respectively. These findings indicated that CDAI can attenuate the adverse effects of DII on metabolic disorders and lung function decline, which provides new insight for diet modification in preventing early lung dysfunction.

3 March 2017 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JWJian-Zhong Wang
Jian-Zhong Wang
JXJing-Jun Xiang
Jing-Jun Xiang
LWLi-Ge Wu
Li-Ge Wu
YBYansen Bai
Yansen Bai
ZCZhuo-Wang Chen
Zhuo-Wang Chen
PXPing Xu
Ping Xu
Recently studies have demonstrated that the long non-coding RNA (lncRNA) metastasis associated lung adenocarcinoma transcript 1 (MALAT1) may participate in the development and progression of lung cancer. In this study, we hypothesized that genetic variant of this lncRNA may affect the prognosis of lung cancer patients. We conducted a follow-up study for 538 patients with non–small cell lung carcinoma (NSCLC), including 140 early-staged (stage I and II) and 398 advanced staged (stage III and IV) patients. The genetic variant rs3200401 in MALAT1 was then genotyped among this population by using TaqMan assay. The association of this variant with overall survival of these patients was further analyzed. It was shown that among the advanced lung adenoma patients, subjects carrying rs3200401 CT and CT + TT genotypes had significantly longer median survival time (MST = 29.9, 28.9 vs. 19.3 month, Long-rank P = 0.019 and 0.024, respectively) and decreased death risks [crude HR (95% CI) = 0.65 (0.43–0.98) and 0.64 (0.44–0.95), P = 0.040 and 0.025, respectively], when compared to subjects wtih the MALAT1 rs3200401 CC genotype. However, the beneficial effect of rs3200401 was not seen among early NSCLC and advanced lung squamous cell carcinoma patients. We further tested the TCGA data, and found that a higher expression of MALAT1 was associated with metastatic of advanced lung adenocarcinoma but not with lung squamous cell carcinoma. The rs3200401 T allele located on the lncRNA MALAT1 was associated with a better survival for advanced lung adenocarcinoma patients, which may offer a novel prognostic biomarker for this patient subgroup. However, these results need to be validated in larger populations of lung cancer and the biological function of this variant still warrants further investigation.

1 October 2023 in Science of The Total Environment
Verified
Journal Article
Closed access
QDQifei Deng
Qifei Deng
YWYanzhu Wei
Yanzhu Wei
KLKang Liu
Kang Liu
DWDegang Wu
Degang Wu
XZXinyu Zhu
Xinyu Zhu
YBYansen Bai
Yansen Bai

9 December 2024 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
BLBaihao Lin
Baihao Lin
WLWanlu Liu
Wanlu Liu
HWHank-Han Wang
Hank-Han Wang
HQHaixia Qian
Haixia Qian
XZXinyu Zhu
Xinyu Zhu
YBYansen Bai
Yansen Bai
Preserved ratio impaired spirometry (PRISm) and airflow obstruction are recognized as critical early signs of chronic obstructive pulmonary disease (COPD). While these conditions arise from concurrent exposure to toxicants and essential nutrients, how vitamin D modifies the pulmonary toxicity induced by polycyclic aromatic hydrocarbons (PAHs) and the metabolic mechanisms involved is still unclear. Based on the National Health and Nutrition Examination Survey (NHANES) 2007-2012, data on urinary PAH metabolites (ΣOH-PAHs), serum vitamin D metabolite levels [Σ25(OH)D], and pulmonary function tests [forced expiratory volume in one second (FEV1), forced vital capacity (FVC) and FEV1/FVC] from 2189 participants, including 369 subjects with early lung dysfunction, defined as PRISm or airflow obstruction. Multiple metabolic disorder indicators were calculated using biochemical markers. The interaction effects between vitamin D and PAHs were evaluated using multiple linear and logistic regression models. Causal mediation analyses and structural equation modeling were employed to investigate the mediating roles of metabolic indicators. PAHs and vitamin D had opposite effects on lung function parameters [FEV1: β (95 CIs) = -0.01 (-0.02, -0.01) vs. 0.01 (0.01, 0.04); FVC: β (95 CIs) = -0.01 (-0.02, 0.01) vs. 0.04 (0.01, 0.06)] and risk of early lung dysfunction [OR (95 CIs) = 1.22 (1.06, 1.40) vs. 0.52 (0.37, 0.73)]. Decreased associations of ΣOH-PAHs with FEV1, FVC, and early lung dysfunction, as well as with metabolic score-visceral adiposity index (MSV) were visualized with increased Σ25(OH)D among subjects with body mass index (BMI) < 28 kg/m2. Furthermore, 2.18 %, 18.20 %, 5.70 %, and 4.70 % of the associations of co-exposure to ΣOH-PAHs and Σ25(OH)D with FEV1, FVC, FEV1/FVC, and early lung dysfunction disease were mediated by MSV. Our findings indicated that vitamin D antagonizes the hazardous effects of PAHs on early lung dysfunction by metabolic alteration, providing new insight into the identification of the underlying high-risk populations and accessible prevention and intervention measures for attenuating PAH-induced lung dysfunction.

23 July 2025 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
WLWanlu Liu
Wanlu Liu
YDYaotang Deng
Yaotang Deng
GLGuoliang Li
Guoliang Li
LYLe Yang
Le Yang
YWYouyi Wu
Youyi Wu
LLLili Deng Lili Liu
Lili Deng Lili Liu
The Lithium nickel manganese cobalt oxide (NCM) is a representative new energy material widely used in industry and daily life, but the systemic health influence of exposure to NCM remained largely unknown. This study aimed to reveal the impacts of NCM exposure on biological age acceleration (BAA) and metabolic alteration, as well as the mediating roles of metabolites. NCM exposure was assessed through three methods: external exposure, biomarker of exposure to NCM mixture (Li, Ni, Co, and Mn), with a particular focus on Li exposure. BAA was calculated using the Klemera and Doubal methods, and untargeted metabolomics was conducted among a representative sample of participants (n = 100). High NCM external exposure showed higher BAA than those with low exposure (median BAA: 0.11 vs. -0.32 years), and increased dose-response relationships between NCM exposure biomarker and BAA were observed using two multi-exposure models. Li was the critical component to NCM exposure effects (weight = 0.793). The "meet-in-the-middle" approach identified twenty-eight metabolites associated with both external and biomarkers of exposure to NCM, Li exposure, and BAA (VIP ≥ 1 and FDR ≤ 0.05). Five key metabolites including TG(50:0)-TG(18:0/16:0/16:0), eicosadienoic acid, Gly-Glu, 2-Oxoarginine, and TG(55:1)-TG(16:0/18:1/21:0) mediated 18.10 %-89.40 % of NCM exposure-BAA association. Our findings provide epidemiological evidence on the hazardous NCM exposure and shed light on metabolic biomarkers for the identification and intervention of accelerated aging among populations.

22 March 2025 in Journal of Advanced Research
Verified
Journal Article
Open access
XZXinyu Zhu
Xinyu Zhu
WLWanlu Liu
Wanlu Liu
BLBaihao Lin
Baihao Lin
HQHaixia Qian
Haixia Qian
MXMengya Xu
Mengya Xu
YBYansen Bai
Yansen Bai
Early life bone accumulation, which predicts future fragility fracture risk, is intimately associated with sex hormones. N, N-diethyl-3-methylbenzamide (DEET) is the primary and most effective active ingredient widely used globally, especially among children and adolescents. However, the effects of DEET on sex hormones and bone mass remain unclear. We aimed to explore the adverse effects of DEET exposure on bone mass and to elucidate the potential mediating roles of sex hormones in children and adolescents. This cross-sectional study analyzed 864 children and adolescents from NHANES 2013-2016. Urinary 3-diethyl-carbamoyl benzoic acid (DCBA) was employed as a biomarker for DEET exposure. The study examined the relationships between DCBA, sex hormones, and bone mass, with a particular focus on evaluating the independent and serial mediation effects of sex hormones on DEET-bone mass associations. Increased DCBA was associated with decreased testosterone (TT), estrogen (E2), and free androgen index (FAI), alongside an increase in sex hormone-binding globulin (SHBG) levels, particularly pronounced among subjects < 12 years [β% (95 % CI) = -0.081 (-0.144, -0.017), -0.064 (-0.114, -0.013), -0.101 (-0.177, -0.024), and 0.020 (-0.009, 0.048), respectively] and non-overweight subjects [β% (95 % CI) = -0.160 (-0.234, -0.086), -0.103 (-0.158, -0.048), -0.195 (-0.282, -0.107), and 0.035 (0.012, 0.058), respectively]. Negative dose-response relationships between DCBA and bone mass were observed in non-overweight participants [β% (95 % CI) = -0.011 (-0.018, -0.005) and -0.027 (-0.041, -0.013) for total bone mineral density (BMD) and total bone mineral content (BMC), respectively], and in children < 12 years for total BMC [β% (95 % CI) = -0.012 (-0.024, 0.000)]. Additionally, TT, E2, and SHBG were found to significantly and independently mediate 15.41 % to 79.84 % of the relationship between DCBA and bone mass. Furthermore, serial mediation effects among sex hormones were detected between TT, E2, and SHBG. DEET exerts a detrimental effect on bone health by interfering with sex hormones in children and adolescents, warranting heightened public concern.